neoplasia1 [compatibility mode]
TRANSCRIPT
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 1/43
Neoplasia Neoplasia
Dr suvarna nalapat
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 2/43
Definition
• Neoplasia is new, uncontrolled growth; a"tumor" or "mass lesion" is simply a "growth"or "enlargement" which may not be neoplastic
(such as a granuloma). The term "cancer"implies malignancy, but neoplasms can besubclassified as either benign or malignant.
• Sir rupert willis”neoplasm is an abnormalmass of tissue ,the growth of which exceeds
and is uncoordinated with that of normal tissueand persists after cessation of the stimuli”
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 3/43
Normal vs neoplastic cells
Autonomous –independent of growth factors and
regulatory mechanisms
Excessive-
Disorganised-
Key words-tumour (swelling)-benign ,malignant
Cancer-malignant tumour
Oncology oncos-greek for the latin tumour-thescince dealing with study of tumours.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 4/43
Benign Neoplasms• slow growth, resemblance to tissue of origin (well
differentiated), circumscription, lack of invasion or metastases.
• solitary (e.g., lipoma of colon, meningioma of dura), but may be multiple (e.g., leiomyomata of uterus,intradermal nevi on skin). cause problems through mass
effect, particularly in tight quarters (pituitary adenomain sella turcica).
• hamartoma benign ,localized but haphazard growth of tissues normally found at a given site (pulmonaryhamartoma has jumbled cartilage, bronchial epithelium,and connective tissue).another eg a mole
• choristoma benign tissue not normal to the site of origin(e.g., salivary gland choristoma of the middleear,pancreatic choristoma in stomach or liver,ectopic brain tissue in nasal cavity.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 5/43
Malignant Neoplasms
• rapid increase in size, lack of differentiation(anaplasia), tendency to spread by invasion or metastases.
• Cytologic features of malignant neoplasms increasednuclear size (with increased nuclear/cytoplasmic ratio-- N/C ratio).
• variation in nuclear or cell size (pleomorphism).
• lack of differentiation (anaplasia).
• increased nuclear DNA content with subsequent dark staining on H and E slides (hyperchromatism).
• prominent nucleoli within the nuclei.• mitoses (especially irregular or bizarre mitoses).
• All of these features are "atypical". Atypia implies achange for the worse from normal.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 6/43
Spread of Malignant
Neoplasms
By direct extension (invasion) into surrounding
tissues.
Through lymph channels to lymph nodes
(lymphatic spread)--typical of carcinomas.
Via the bloodstream (hematogenous spread)--
typical of carcinomas or sarcomas.
Within body cavities (seeding)--typical of
neoplasms in peritoneal cavity
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 7/43
The spread of malignant
neoplasms determines the
stage
In-situ (refers to epithelial malignancies
confined to just the epithelium withoutgoing throug the basement membrane).
Microinvasion (spread of epithelial
malignancies just beyond the point of
origin through the basement membrane).
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 8/43
Local invasion (spread
within the organ of originor to contiguous
structures).
Local metastases (non-
contiguous spread of the
neoplasm within the organof origin or to the lymph
nodes closest to the organ
of origin).
Distant metastases (spread
to other organs or to far
away lymph nodes)
•
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 9/43
The indicators that a neoplasm is
malignant are:
Metastases (best indicator) and Invasion (next best indicator
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 10/43
Grading of neoplasms
• Based upon: differentiation (the degree to which theneoplasm resembles the tissue of origin) along withthe degree of atypia.
• well-differentiated--looks very similar to normal tissue
• moderately differentiated--looks something likenormal
• poorly differentiated--hardly looks like normal tissue
• anaplastic--virtually no similarity to normal tissue
• Both staging and grading schemes are devised toclassify malignant neoplasms for determiningappropriate treatment and to try and determine the prognosis. In general, the higher the stage or thehigher the grade, the worse the prognosis.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 11/43
Appearances of Neoplasms
• Desmoplasia the proliferation of non-neoplasticconnective tissue in association with neoplasia (givestumors a firm, fibrous, "scirrhous" appearance) andmay distort surrounding tissues.
• Neoplasms mimic tissue of origin, but not always.Larger masses tend to undergo central necrosis.
Metastases usually look similar to primary, but notalways.
• primary site is ususally a single large mass in anorgan, while multiple masses in an organ usuallyindicate metastases.
• It is not always possible to tell benign from malignant based upon histologic or cytologic criteria alone. biologic behavior of neoplasm may not alwayscorrelate with appearance, making choice of treatmentmore difficult.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 12/43
• The process of
neoplasia is
represented
symbolically
•Oncogenesis
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 13/43
Nomenclature of Neoplasia
• Based upon origin:
• Maligant neoplasms arising from tissueembryologically derived from ectoderm or
endoderm are usually carcinomas. Examplesinclude:
• Squamous cell carcinoma of cervix
• Adenocarcinoma of stomach
• Hepatocellular carcinoma• Renal cell carcinoma
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 14/43
Malignancies arising from mesoderm are
usually sarcomas. Examples include:
Leiomyosarcoma
Chondrosarcoma
Osteosarcoma
Liposarcoma
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 15/43
• Neoplasms with more than one cell type but
arising from only one germ layer are called
"mixed tumors". The best example is the
benign mixed tumor (also called pleomorphicadenoma) of salivary gland.
• Neoplasms with more than one cell type and
arising from more than one germ layer are
called teratomas. Such neoplasms are commonin the ovary.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 16/43
Neoplasms ending in "-
blastoma"• resemble primitive embryonic tissues:
• Retinoblastoma
• Neuroblastoma• Hepatoblastoma
• Medulloblastoma
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 17/43
Not all malignant neoplasms have benigncounterparts:
Hematopoietic and lymphoid cells (as in bone
marrow and lymph node) give rise to leukemiasand lymphomas. They have no benigncounterpart.
Gliomas (astrocytomas, oligodengrogliomas,glioblastoma multiforme, etc) arise from glialcells in the CNS. They have no benigncounterpart
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 18/43
Carcinomas
• Arise from epithelial surfaces (in gastrointestinal tract,in respiratory tract, in urogenital tract, in biliary tract,in skin) and in organs with epithelial-lined ducts(breast, pancreas, salivary gland, liver). Endocrine
glands, including testis and ovary, may also give riseto carcinomas. In general, carcinomas are composedof polygonal-shaped cells.
• Carcinomas that form glandular configurations arecalled adenocarcinomas.
• Carcinomas that form solid nests of cells with distinct borders, intercellular bridges, and pink keratinizedcytoplasm are called squamous cell carcinomas.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 19/43
Sarcomas
• Arise from soft tissues (connective tissues
such as cartilage, bone, or fascia, smooth or
skeletal muscle, blood vessels, lymph vessels,
coverings of organs such as mesothelium). Ingeneral, sarcomas are composed of very
pleomorphic spindle-shaped cells. Sarcomas
are generally big and bad.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 20/43
Biology of Neoplasia
• This subject attempts to determine what gives
rise to neoplasms and what controls their
growth.
Causes of Neoplasia
• The origin for many neoplasms is obscure.
However, there are several theories of origin
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 21/43
Environmental causes:
• Chemicals (aniline dyes and bladder cancer), drugs(cigarette smoke and lung cancer), and naturalcompounds (aflatoxins and liver cancer) carcinogenic.
• Oncogenic viruses human papillomavirus (HPV)implicated in most squamous cell carcinomas of cervix and anogenital squamous papillomas, Epstein-Barr virus (EBV) implicated in African Burkitt'slymphoma, and hepatitis B virus (HBV) implicated indevelopment of hepatocellular carcinomas.
• Radiation (such as ultraviolet light and skin cancers;gamma radiation and leukemia, thyroid, lung, colon,and breast cancers). Ultraviolet light induces pyrimidine dimers in DNA. Ionizing radiation inducesmutations in DNA
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 22/43
Hereditary causes:
• Chromosomes which have absent or defective anti-
oncogenes that control growth (retinoblastoma results
from defective chromosome 13)• Obscure defects: racial predilections (American
women have breast cancer more often than Japanese
women; Japanese men have stomach cancer far more
often than American men).
• Age: older persons have a greater propensity todevelop neoplasms from lack of effective control
mechanisms.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 23/43
Altered DNA:
• All the above mediated by the cause, producing a
mutation in, or damage to, cell DNA
• mutations involving tumor suppressor genes (such as
p53),. The majority of human neoplasms probablyarise via this mechanism.
• In some cases these mutations are probably mediated
by proto-oncogenes (genes which control cellular
growth) that undergo mutation to oncogenes which
give rise to neoplasia. Proto-oncogenes can beactivated by point mutations, translocations, and by
gene amplification
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 24/43
• An example of this is chronic myelogenous leukemia
(CML) which is a neoplastic proliferation of white
blood cells. All cases of CML have the "Philadelphia
chromosome" which is a translocation betweenchromosomes 9 and 22. This translocation juxtaposes
the proto-oncogene ABL with the breakpoint cluster
region (BCR) on chromosome 22. The chimeric ABL-
BCR gene leads to production of a mutant protein with
enhanced tyrosine kinase activity. This protein may
play a role in regulation of cell growth in CML.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 25/43
• About 15 to 20% of human cancers have been linkedto oncogenic activity. The ras oncogene is thetransforming gene found most frequently in humancancers.
• Oncogenic viruses may bring oncogenes with them,so-called viral oncogenes (typical of RNA containing"retroviruses" such as human T-lymphotropic viruses(HTLV's).
• Growth factors such as epidermal growth factor
(EGF), platelet-derived growth factor (PDGF) andcolony-stimulating factor-1 (CSF-1) assist oncogeneactivity. Transforming growth factor (TGF-alpha) also promotes tumor growth.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 26/43
Tissue evidence of
carcinogenic factors at work Metaplasia: an initial change from normal cells to
a different cell type (such as chronic irritation of cigarette smoke causing ciliated pseudostratified
epithelium to be replaced by squamousepithelium more able to withstand the insult
Dysplasia: an increasing degree of disorderedgrowth or maturation of the tissue (often thoughtto precede neoplasia) such as cervical dysplasia
as a result of human papillomavirus infection.Dysplasia is still a reversible process. However,once the transformation to neoplasia has beenmade, the process is not reversible
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 27/43
Metaplasia - dysplasia -
Neoplasia. best evidenced inuterine cervix and respiratory
tract
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 28/43
Chemical carcinogenesis
initiation and promotion
• initiating carcinogenic agent irreversibly damages cellDNA (mutagenic). Examples : alkylating agents likecyclophosphamide, polycyclic aromatic hydrocarbonslike epoxides found in smoked foods, aromatic amines
or azo dyes used in food coloring, aflatoxins in moldy peanuts, nitrosamines in pickled foods.
• promoting agent (may be the same as the carcinogen)then acts (reversibly) to cause proliferation of neoplastic cell clone, but there appears to be a "dose-
threshold" concentration of promoter below whichneoplasia will not occur. Examples of promotersinclude: hormones such as estrogen, drugs such asdiethylstibesterol, and chemicals such as cyclamatesused as sweeteners
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 29/43
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 30/43
Malignant neoplasms do not tend to arise from benign neoplasms (e.g., malignant melanomas donot come from benign nevi) though in some cases
such as adenomas of the colon, the appearance of the benign neoplasm is a step toward possiblemalignancy.
There are "pre-cancerous" conditions in whichmalignant neoplasia is more likely to occur (but
not in every case): liver cirrhosis, chroniculcerative colitis, atrophic gastritis, epidermalactinic keratosis, oral leukoplakia
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 31/43
Clonality
Neoplastic cells tend to be monoclonal, or similar in genetic makeup, indicating origin from atransformed cell. Non-neoplastic proliferations
(such as reactions to inflammation) have cellsthat are polyclonal in origin.
The concept of "tumor progression" holds thatsubclones may arise over time from the originalmalignant clone. These subclones may differ
from the original clone in characteristics such asinvasiveness, metastatic potential, and responseto therapy
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 32/43
Tumor Genetics
• Neoplasms have a greater tendency to
karyotypic abnormalities such as
translocations, deletions, and gene
amplifications (which are also activators of proto-oncogenes). Leukemias and lymphomas
are famous for this, as with the Philadelphia
(Ph1) chromosome of chronic myelogenous
leukemia and the t(8:14) translocation inBurkitt's lymphomas
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 33/43
Tumor growth
less differentiated a neoplasm, faster it grows.
cell cycle of neoplastic cells is not shortened,
rather the growth fraction of cells proliferating is
increased. This is offset by neoplastic cell death.Tumor growth is expressed as a "doubling time"
or the time to increase twice in volume (e.g.,
from 1 to 1.3 cm diameter). An aggressive
malignant neoplasm doubles in 1 to 3 months,while benign neoplasms double in years.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 34/43
Some neoplastic growth is influenced by host
factors. Estrogenic hormones aid growth of
breast fibroadenomas or carcinomas and uterine
leiomyomas because the tumor cells havehormone receptors.
Growth is also dependent upon the ability of the
tumor to develop a blood supply. Factors secreted
by neoplastic cells promote angiogenesis andfibroblast proliferation.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 35/43
Characteristics of
Transformed (Neoplastic)
Cells
Neoplastic cell growth is not inhibited by contactwith surrounding cells and is not dependent on
anchorage to a solid surface. Neoplastic cells may attain "immortality" or the
ability to keep dividing indefinitely.
They are discohesive and transplantable--favoring invasion and metastasis.
Tumor cells can bind to laminin and fibronectinin connective tissues, then secrete collagenases or
proteases, and then invade
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 36/43
Epidemiology of Neoplasia
• Neoplasms can be characterized by:
• Their incidence (how often they occur).
• Their death rate (how many deaths are caused
by them).• A neoplasm such as basal cell carcinoma of
the skin can be quite common, yet it almostnever kills the patient. On the other hand,gliomas of the brain are uncommon butvirtually always kill the patient. One in 5Americans dies of cancer.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 37/43
Men Women
Prostate 317,000 Breast 184,000
Lung 112,000 Colon-rectum 82,000
Colon-rectum 68,000 Lung 78,000
Bladder 38,000 Endometrium 34,000
Lymphomas 35,000 Lymphomas 26,000
Incidence of Neoplasia
(estimated new cases for 1996 for malignant neoplasms in the U.S.)
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 38/43
Deaths from Neoplasia
(top death-causing malignant neoplasms in the U.S. estimated for 1996)
Men Women
Lung 94,000 Lung 64,000
Prostate 41,000 Breast 44,000
Colon-Rectum 27,000 Colon-Rectum 28,000
Pancreas 14,000 Ovary 15,000
Lymphomas 13,000 Pancreas 14,000
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 39/43
• These data indicate that some cancers such as prostate
and breast are more amenable to therapy than lung or
pancreas. Another measure of therapeutic
effectiveness is the so-called "5-year survival".
Treatments can be compared based upon who survived
the longest.
• The incidence of some tumors in the U.S. is increasing
(lung) while others are decreasing (stomach).
Environmental factors influence incidences fromlocation to location and race to race.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 40/43
Important to remember:
• the incidence of cancer varies greatly with age.
Testicular cancers and Hodgkin's disease are
seen mostly in young adult males, while
prostate cancers are more frequent in older men. Of malignant neoplasms in children,
leukemias and brain tumors are most frequent.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 41/43
Effects of neoplasia on the
body
Mass effect: impinging on a vital area (airway,nerve, blood vessel, hollow viscus) to obstruct or destroy it, or lead to infarction or infection.
Local destruction: invasion or lysis of epithelialsurfaces or vascular channels, leading toulceration, bleeding, and infection.
Cachexia: either caloric intake is decreased (lack of appetite or inability to eat) or the neoplasm
alters normal metabolism (tumor necrosis factor);cancers do not "eat" the calories themselves.
7/31/2019 Neoplasia1 [Compatibility Mode]
http://slidepdf.com/reader/full/neoplasia1-compatibility-mode 42/43
Functional activity: production of a hormone or substance that has an untoward effect. Many of these are so-called "paraneoplastic" syndromes
(such as an oat cell lung cancer secreting ACTHor a renal cell carcinoma secreting erythropoietinor an islet cell tumor producing insulin).
Hypercalcemia often accompanies cancers and isdue either to: (1) osteolysis from metastases to
bone or (2) production of parathormone-likesubstance (often in squamous cell carcinomas).